Published in Pharma Law Weekly, November 10th, 2009
Addus has granted the underwriters a 30-day option to purchase up to an additional 810,000 shares to cover over-allotments, if any.
Robert W. Baird & Co. and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly